Evidence map›Paper›PMID 41260898›Full record

ArticleRNA (New York, N.Y.)2026

Novel trinucleotide mRNA capping reagents: improved synthetic route and efficient cotranscriptional incorporation in mRNA.

Chunping Xu, Russell Cousins, Ilya Ilichev, Jesus Ceja, Paul Ludford, Vagarshak Begoyan, Marc Turner, Maria Santos, Coleen Vo, Farinaz Rezvani and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RNA (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chunping XuTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA cxu@trilinkbiotech.com.
Russell CousinsTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Ilya IlichevTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Jesus CejaTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Paul LudfordTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Vagarshak BegoyanTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Marc TurnerTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Maria SantosTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Coleen VoTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Farinaz RezvaniTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Andrew UjitaTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Jordana HendersonTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Michael HoustonTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Chanfeng ZhaoTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.
Alexandre V LebedevTriLink Biotechnologies, part of Maravai Life Sciences, San Diego, California 92122, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 5'-

Indexed as

RNA CapsRNA, MessengerTranscription, GeneticRNA CapsRNA, MessengerIVTmRNAtrinucleotide capping reagents

Identifiers

PMID41260898
PMCPMC12810185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.